Your browser is no longer supported. Please, upgrade your browser.
FWP [NASD]
Forward Pharma A/S
Index- P/E- EPS (ttm)-0.94 Insider Own- Shs Outstand6.92M Perf Week5.41%
Market Cap52.18M Forward P/E- EPS next Y- Insider Trans- Shs Float0.48M Perf Month11.27%
Income-6.40M PEG- EPS next Q- Inst Own13.80% Short Float0.52% Perf Quarter-13.33%
Sales- P/S- EPS this Y78.40% Inst Trans0.11% Short Ratio0.06 Perf Half Y20.74%
Book/sh11.36 P/B0.69 EPS next Y- ROA-8.20% Target Price- Perf Year23.22%
Cash/sh- P/C- EPS next 5Y21.00% ROE-8.30% 52W Range5.65 - 10.15 Perf YTD10.95%
Dividend- P/FCF- EPS past 5Y58.60% ROI- 52W High-23.15% Beta1.68
Dividend %- Quick Ratio74.50 Sales past 5Y- Gross Margin- 52W Low38.05% ATR0.42
Employees4 Current Ratio74.50 Sales Q/Q- Oper. Margin- RSI (14)58.88 Volatility4.60% 5.93%
OptionableNo Debt/Eq0.00 EPS Q/Q83.00% Profit Margin- Rel Volume0.17 Prev Close7.57
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume42.26K Price7.80
Recom- SMA205.16% SMA508.50% SMA20013.06% Volume7,242 Change3.04%
Apr-03-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Apr-03-17Downgrade Jefferies Buy → Hold
May-26-15Reiterated RBC Capital Mkts Outperform $40 → $45
May-13-15Reiterated RBC Capital Mkts Outperform $33 → $40
May-07-15Reiterated Jefferies Buy $40 → $43
Apr-24-15Reiterated Leerink Partners Outperform $43 → $53
Apr-20-15Reiterated Leerink Partners Outperform $40 → $43
Nov-10-14Initiated RBC Capital Mkts Outperform $33
Apr-14-21 04:40PM  
Jan-12-21 04:30PM  
Jul-14-20 04:01PM  
May-12-20 05:00PM  
Apr-24-20 04:50PM  
Jan-10-20 08:05PM  
Dec-20-19 05:13PM  
Nov-26-19 04:05PM  
Jun-26-19 04:30PM  
May-27-19 08:49AM  
Apr-04-19 04:30PM  
Mar-27-19 08:30AM  
Oct-24-18 11:11AM  
10:53AM  
10:42AM  
10:20AM  
Sep-28-18 07:30AM  
Sep-20-18 09:02AM  
Sep-19-18 04:20PM  
Aug-23-18 08:00AM  
May-23-18 08:20AM  
May-07-18 04:30PM  
Apr-30-18 04:40PM  
Feb-07-18 07:30AM  
Jan-29-18 10:44AM  
Dec-21-17 05:00PM  
Nov-29-17 04:30PM  
Nov-27-17 07:30AM  
Nov-22-17 04:30PM  
Nov-15-17 08:02AM  
Nov-09-17 04:30PM  
Oct-09-17 07:40AM  
Sep-26-17 04:15PM  
Sep-13-17 08:10AM  
Sep-08-17 08:56AM  
Sep-05-17 05:00PM  
Sep-01-17 07:00AM  
Aug-02-17 04:45PM  
Jul-18-17 08:05AM  
Jun-14-17 08:00AM  
Jun-02-17 08:30AM  
May-31-17 08:30AM  
May-01-17 08:30AM  
07:30AM  
Apr-18-17 05:15PM  
Apr-07-17 08:33AM  
Apr-03-17 03:42PM  
06:26AM  
Mar-31-17 06:59PM  
05:14PM  
02:45PM  
01:02PM  
12:27PM  
12:15PM  
12:10PM  
Mar-01-17 09:15AM  
Feb-09-17 08:30AM  
Feb-03-17 11:03AM  
Feb-02-17 09:30AM  
Feb-01-17 02:22PM  
09:15AM  
Jan-26-17 06:41AM  
Jan-18-17 12:46PM  
08:29AM  
08:02AM  
Jan-17-17 05:23PM  
12:00PM  
11:14AM  
11:05AM  
11:01AM  
10:05AM  
09:45AM  
07:52AM  
Jan-11-17 10:48AM  
Dec-19-16 05:04PM  
Dec-15-16 08:15AM  
Dec-13-16 05:43AM  
Dec-06-16 10:06AM  
Nov-30-16 04:22PM  
Nov-29-16 04:34PM  
04:15PM  
Nov-02-16 08:00AM  
Sep-14-16 08:39AM  
Sep-13-16 03:17PM  
Sep-06-16 08:00AM  
Sep-01-16 08:00AM  
Jul-20-16 02:51PM  
Jul-11-16 07:16PM  
Jun-08-16 06:02PM  
Jun-06-16 04:15PM  
Jun-02-16 04:15PM  
May-09-16 04:01PM  
May-02-16 08:30AM  
Apr-16-16 01:04PM  
Apr-12-16 04:15PM  
Mar-15-16 08:15AM  
Feb-15-16 10:28AM  
Feb-09-16 09:23AM  
Dec-08-15 01:08PM  
Nov-30-15 02:50PM  
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.